Delivery Order SPE2DB20D2104-SPE2DB22FT86B
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $12,221.22 firm fixed-price delivery order is for the supply of Mesalamine DR 1.2 GM tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, for the supply of 120 tablets of the pharmaceutical product Mesalamine DR 1.2 GM. The $7,899.33 contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any...
- This delivery order, awarded on January 30, 2026, provides Mesalamine 1.2 GM tablets (120-count supply) to the Defense Logistics Agency (DLA) under a firm fixed-price contract valued at $4,901.76. The award was made to AmerisourceBergen Drug Corp, the corporate office division of Cencora, Inc., with performance taking place at the company's Conshohocken, Pennsylvania headquarters. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,514.61 for the supply of the pharmaceutical product LIALDA DR 1.2 GM TABLET 120S. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which...
- This federal contract award, valued at $64,463.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for 4566583099 - MESALAMINE 800 MG DR TABLET 180S, with a firm fixed price and an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Mesalamine 800 mg delayed-release tablets over a one-year period. The award, made by the Defense Logistics Agency (DLA), is a firm-fixed price delivery order with a ceiling value of $16,829.06. The contract has no set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds several indefinite delivery contracts (IDCs) with federal agencies, including a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,300.50 and is a firm fixed-price contract for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a medical product. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of 4,565,603,251 units of Mesalamine 800 mg delayed-release tablets in 180-count bottles to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $11,886.16 firm-fixed-price delivery order (SPE2DX15D3109) was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the federal government. This order is part of a larger $999,999,999 Indefinite Delivery Contract (SPE2DX24FXWRT) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,209.50 delivery order contract is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a medical product used in the treatment of various conditions. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at $10,592.35 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) with a completion deadline of January 16, 2026. This non-set-aside, competitively awarded contract features firm fixed-price pricing and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. Cencora's prime IDC, valued at up to $999.9...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT86BDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $2,442.89 firm fixed-price delivery order for the supply of 4,558,384,672 units of the pharmaceutical Mesalamine DR 1.2 GM tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 9, 2022. This delivery order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/8/22 |